The antimicrobial efficacy of innovative 3D triple antibiotic paste-mimic tubular scaffold against actinomyces naeslundii by Azabi, Asma Abulqasem
  
 
 
  
 
THE ANTIMICROBIAL EFFICACY OF INNOVATIVE 3D TRIPLE 
ANTIBIOTIC PASTE-MIMIC TUBULAR SCAFFOLD  
AGAINST ACTINOMYCES NAESLUNDII  
 
 
 
 
by 
Asma Abulqasem Azabi 
 
  
 
 
 
 
 
 
 
Submitted to the Graduate Faculty of the School 
of Dentistry in partial fulfillment of the requirements 
for the degree of Master of Science in Dentistry, 
Indiana University School of Dentistry, 2015. 
 
ii 
 
 
    
 
Thesis accepted by the faculty of the Department of Restorative Dentistry, Indiana 
University School of Dentistry, in partial fulfillment of the requirements for the degree of 
Master of Science in Dentistry. 
 
 
  ____________________________ 
                                                                  Richard L. Gregory  
 
 
 
____________________________ 
                                                                  Kenneth J. Spolnik 
 
  
 
____________________________ 
                                                            N. Blaine Cook  
 
 
 
____________________________ 
                                                               Marco C. Bottino 
                                                                      Chair of the Research 
                                                     Committee  
 
 
 
____________________________ 
                                                                       Tien-Min Gabriel Chu  
                                                               Program Director 
 
 
                 
      
____________________________  
             Date 
iii 
 
 
    
 
 
 
 
 
 
 
 
 
 
DEDICATION 
 
 
 
 
 
 
 
  
iv 
 
 
    
 
 
 
 
 
 
 
 
 
This thesis is dedicated to all the people 
 who sustain me in life. 
To my dear parents – my father, my role model, who supported my ambition 
 and my pursuit of knowledge; 
 and my mother, always by my side with prayers and unconditional love. 
To my lovely family – my husband and children, who have brought 
 happiness and meaning 
 to my life. 
 
 
 
 
  
v 
 
 
    
 
 
 
 
 
 
 
 
 
  
ACKNOWLEDGMENTS 
  
vi 
 
 
    
 
 
 
First, my success and achievements come only from God.  In Him I trust and unto 
Him I repent.  
I would like to convey my sincere gratitude to my home country, Libya, for 
honoring me with this opportunity to continue my postgraduate education. One day I 
shall invest my knowledge in improving my country. 
My special thanks to my husband for supporting me and standing by my side 
throughout all the stressful times. 
I would like to express my deepest appreciation to my mentor, Dr. Marco C. 
Bottino, for his guidance, help, and support.   
I also would like to thank my research committee members, Drs. Tien-Min 
Gabriel Chu, Kenneth J. Spolnik, N. Blaine Cook, and Richard L. Gregory for their 
guidance, suggestions, and help throughout my research project.  
My sincerest gratitude goes to Dr. Tereza Albuquerque for her knowledge, help, 
and support that guided me to finish my research. 
Finally, I would like to thank my friends, colleagues, and all Indiana University 
staff members for their patience, help, and support throughout my study. 
 
  
vii 
 
 
    
 
 
 
 
 
 
 
 
 
 
 
TABLE OF CONTENTS 
  
viii 
 
 
    
 
Introduction…………………………………………………………..    1 
Review of Literature…………………………………………………    7 
Methods and Materials………………………………………………  26 
Results……………………………………………………………….  32 
Tables and Figures………………………………………………….  34 
Discussion……………………………………………………………  61 
Summary and Conclusions…………………………………………..  65 
References……………………………………………………………  67 
Abstract………………………………………………………………  78 
Curriculum Vitae   
 
 
  
ix 
 
 
    
 
 
 
 
 
 
 
 
 
 
LIST OF ILLUSTRATIONS  
 
  
x 
 
 
    
 
FIGURE 1 Image of electrospinning set-up used in the current study located in 
Dr. Bottino’s laboratory…………………………………………... 
 
35 
FIGURE 2 Image showing the scaffold collected on the rotating mandrel of the 
electrospinning apparatus…………………………….…………….. 
 
36 
FIGURE 3 Tubular electrospun scaffold after being collected on the rotating 
mandrel during the electrospinning process. This shows how the 
scaffold is cut to 1-mm high 3D scaffolds……………………….... 
 
 
 
37 
FIGURE 4 Schematic drawing showing the dimensions of the dentine 
specimen……………………………………………………………. 
 
38 
FIGURE 5 Image showing NaOCl and EDTA solutions and the ultrasonic bath 
used to clean the prepared specimens………………………………. 
 
39 
FIGURE 6 Dentin specimens placed inside microcentrifuge tubes with 500 µL 
BHIS broth…………………………………………………………. 
 
40 
FIGURE 7 Image showing the centrifuge machine loaded with microcentrifuge 
tubes containing the dentin specimens……………………...……… 
 
41 
FIGURE 8 Image showing fitting the 3D scaffold inside the canal space of the 
dentin specimen…………………………………………………….. 
 
42 
FIGURE 9 Image showing dentin specimens with 3D TAP 
scaffolds (experimental group) placed inside 24 well plates……….. 
 
43 
FIGURE 10 Image showing dentin specimens with 3D scaffolds (control group) 
placed inside 24 well plates……………………………………….... 
 
44 
FIGURE 11 Image showing the mixed TAP solution placed inside the root canal 
space of a dentine slice……………………………………………... 
 
45 
FIGURE 12 Sputter coating of the specimens prior to SEM imaging…………… 46 
FIGURE 13 SEM image of the root canal surface which was analyzed to verify 
the presence of the bacterial biofilm…………………………...…… 
 
47 
 
FIGURE 14 Confocal laser scanning microscope……………………………...... 48 
 
FIGURE 15 Image showing the stained dentin specimens viewed under the 
CLSM lens………………………………………………………….. 
 
49 
 
  
xi 
 
 
    
 
FIGURE 16 Schematic drawing showing the areas scanned by CLSM…………. 50 
 
FIGURE 17 CLSM macrophotographs of 7-day A. naeslundii biofilm (negative 
control) growth inside dentinal tubules……………………………. 
 
51 
 
FIGURE 18 CLSM macrophotographs of infected dentin treated with 
pure PDS............................................................................................ 
 
52 
 
FIGURE 19 CLSM macrophotographs of infected dentin treated with 3D TAP-
mimic scaffold…………………………………………………….... 
 
53 
 
FIGURE 20 CLSM macrophotographs of infected dentin treated with TAP….… 54 
 
FIGURE 21 SEM images of A. naeslundii biofilm on the dentin surface 
(negative control)…………………………………………………… 
 
55 
 
FIGURE 22 SEM images of infected dentin specimen treated with pure PDS….. 56 
 
FIGURE 23 SEM images of infected dentin specimen treated with 3D TAP-
mimic scaffold……………………………………………………… 
 
57 
 
FIGURE 24 SEM images of infected dentin specimen treated with TAP……… 58 
 
FIGURE 25 Graph representing comparison of live bacteria percentage for each 
of the four groups…………………………………………………... 
 
59 
 
TABLE I Percentage of live and dead bacterial cells based on CLSM 
analysis…………….……………………………………………….. 
 
60 
 
 
 
1 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
 
  
 
  
 
2 
 
    
 
 
 
The field of dental biomaterials has witnessed a great revolution. Many material 
choices with superior aesthetic, biological, and mechanical properties have become 
available to restore or replace damaged and lost dental structure. However, when 
compared with the natural tooth structure, such materials often fail to provide the same 
longevity and functionality. Therefore, preserving and regenerating tooth structure is the 
scope of modern dentistry.  
Preserving teeth during early and mixed dentition stages is essential to achieve 
proper function and occlusion in the permanent dentition.
1
 As teeth start to erupt, their 
roots continue to develop to reach the final length and form. Root development continues 
up to three years after tooth eruption.
2
 Maintaining the vitality of the dental pulp is 
essential to the completion of root development and to achieve apical closure. 
Unfortunately, pulpal inflammation and necrosis are very common in immature teeth. 
Dental caries and trauma are the main reasons for pulpal necrosis.
3
 
Dental caries is a time-dependent multifactorial disease, which, if not treated, may 
lead to the penetration of bacteria and bacterial by-products into the dental pulp. Upon 
repeated and persistent insult, the pulp tissue undergoes chronic irreversible 
inflammation, ultimately leading to pulp necrosis and fibrosis. 
Trauma, on the other hand, is a very common reason for pulp necrosis. It has been 
reported that 30 percent of children and 33 percent of adult permanent teeth are subjected 
to trauma.
4,5
 Trauma can result in a partial or complete crushing of the apical blood 
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vasculature responsible for nourishing the dental pulp. Loss of blood supply eventually 
leads to pulp necrosis in about 1 percent to 16 percent of these traumatized teeth.
6
   
Traditional root canal treatment that involves debridement, instrumentation, and 
obliteration of the pulp canal space is the conventional treatment modality for necrotic 
teeth. However, necrotic teeth with incomplete root development pose a particular 
challenge for this approach. Given the wide, open apex, which halts the possibility of 
achieving an apical seal, and the thin dentinal walls, making them more prone to fracture, 
performing traditional root canal treatment on necrotic immature teeth is not advisable.
7
  
Apexification is the most commonly used endodontic treatment in cases of 
immature teeth. It relies on the use of calcium hydroxide (       ) or mineral trioxide 
aggregate (MTA) to induce the formation of a mineralized barrier resulting in the closure 
of the apical foramen.
8
 However, this approach eliminates any further possibility for 
complete root development (e.g., increased dentin wall thickness and ending apical 
formation) increasing future root fracture risks.
9,10
  
Regenerative treatment, on the other hand, could promote further root 
development improving the long-term prognosis of immature teeth. Regenerative 
endodontic procedures (REPs) are biologically-based approaches that aim to restore not 
only the function, but also the anatomy of the damaged structures.
7
 The concept of this 
approach is to regenerate/revitalize the necrotic pulp by utilizing the multipotent nature of 
stem cells derived from the periapical papilla (SCAPs). These cells can be introduced into 
the root canals once periapical bleeding is induced to act as a fibrin-based scaffold and 
develop a new pulp tissue.
7
 However, the establishment of aseptic root canals 
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environment is a prerequisite to ensure a successful outcome of the regenerative 
strategy.
7,11,12
  
Different bacterial species have been isolated from endodontically involved 
teeth.
13,14
 Some of these bacteria have biofilm formation ability ranging from moderate 
(e.g., Enterococcus faecalis, Lactobacilli spp., and Prevotella buccae) to high complexity 
(e.g, Actinomyces spp, Streptococcus mutans and Pseudoramibacter alactolyticus).
15
 
Actinomyces naeslundii, a Gram-positive filamentous, rod-shaped facultative anaerobe 
commonly found in the oral cavity, has been reported to be associated with failed 
endodontic therapy.
14,16
  Moreover, recent findings have identified A. naeslundii as the 
predominant bacterium in immature teeth with necrotic pulps due to trauma.
17
 These 
findings encourage studies to test the effectiveness of traditional and new intracanal 
medicaments and irrigant solutions against A. naeslundii biofilms. According to the 
literature, the presence of minocycline within the so-called TAP should display an 
effective antimicrobial action against A. naeslundii biofilm (MIC = 0.23 µg/mL).
18,19
 
Among the several available intracanal medicament options for regenerative 
endodontics, triple antibiotic paste (TAP), is the most widely used treatment. Although 
local application of TAP may offer advantages, such as effective root canal disinfection 
and a decrease in conceivable systemic complications compared with systemic antibiotic 
administration (e.g., antibiotic resistant strains, cytotoxicity, allergic reactions), the use of 
TAP has been related to significant drawbacks, including damage to stem cells and 
notable tooth discoloration.
4,11,20
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Electrospun polymer-based antibiotic-containing scaffolds have been shown to be 
an effective strategy in achieving root canal disinfection by delivering small yet effective 
amounts of antibiotics.
21,22
  
Therefore, the aim of this study is to produce a new tubular shaped three-
dimensional (3D) TAP-mimic scaffold to fit inside the root canal, and to analyze whether 
using the 3D-shaped antibiotic-containing scaffold will be able to completely eradicate A. 
naeslundii biofilm formed inside the dentinal tubules.  
 
CLINICAL SIGNIFICANCE 
A drug-releasing 3-D scaffold possesses favorable characteristics that could 
dramatically improve the outcome of the regenerative endodontic treatment. The unique 
nanoporous structure of the electrospun scaffold provides a more predictable skeleton to 
support the development of the newly regenerated pulp tissue. In addition, the slowly- 
released lower antibiotic dose imposes less toxicity upon the periapical stem cells 
(SCAPs), which will be later used in regenerating the pulp tissue.  
 
PURPOSE OF THE STUDY 
To determine the antimicrobial effect of 3D TAP-mimic scaffolds against A. 
naeslundii biofilm formed inside the dentinal tubules.  
 
HYPOTHESES 
 
Null Hypothesis 
The null hypothesis is that the 3D TAP-mimic scaffolds will not have 
antimicrobial activity against A. naeslundii biofilm. 
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Alternative Hypothesis 
The alternative hypothesis is that the 3D TAP-mimic scaffolds will display  
antimicrobial activity similar to or better than the TAP against A. naeslundii biofilm. 
 
7 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
 
 
 
 
 
 
 
 
 
 
8 
 
    
 
 
 
 
 
 
THEORIES AND TRADITIONAL TREATMENT 
MODALITIES FOR IMMATURE NECROTIC TEETH  
 
 Immature teeth with necrotic pulp have always been a challenge for endodontic 
treatment. In the past, different treatment approaches were suggested to overcome the 
problems associated with these teeth (wide, open apical foramen and thin dentinal walls). 
According to L.A. Friend in 1966, three basic methods existed to carry out a root canal 
filing in immature teeth.
23
  The first method was to use a custom filling material such as 
gutta-percha. This material would be shaped extra-orally by the clinician and then fitted 
and cemented into the root canals. The problem was the difficulty of achieving a uniform 
seal throughout the apical third, which is usually wider than the coronal third; given the 
thin dentinal walls, instrumentation could not be performed to achieve a favorable conical 
root canal form.
23,24
 The second method was to use a paste endodontic filling material. 
The material was injected into the canal space to achieve a uniform seal. However, the 
possibility of overfilling into the periapical tissue was one of the drawbacks of this 
approach. In the third method, advocated by Ingle 1965, a surgical intervention in the 
form of apicectomy is carried out simultaneously with a root canal filling. In this case an 
amalgam retrograde filling is properly condensed after the apicectomy to achieve an 
apical seal.
23,25
 However, such a surgical approach is not advisable in children, who 
constitute the majority of immature necrotic teeth cases. In addition, apicectomy will 
result in a further shortening of the already short roots.
25
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            Due to the limited success of the above described methods, a general interest in 
further root development or even the formation of an apical barrier was aroused. 
Nygaard-Ostby believed that the induction of bleeding by lacerating the periapical tissue 
will lead to the formation of a newly vascularized pulp tissue within the canal space 
resulting in a continued root development.
26
 Moller et al. demonstrated that a successful 
canal debridement, which involves a complete removal of the infected pulp tissue, would 
create an environment that promotes the development of an apical closure without the use 
of medicaments.
27
 The same hypothesis was promoted by McCormick et al. believing 
that complete pulp canal debridement is a critical factor in apexification.
28
 Although  
most prescribed techniques involved the placement of a medicament after canal 
debridement, many authors believed that apical closure could still occur. Some authors 
also suggested that instrumentation of the pulp canal should be kept to a minimum, if at 
all.
29
  They hypothesized that instrumentation could halt further root development by 
traumatizing the remnants of Hertwig’s epithelial root sheath, which could potentially 
organize the apical mesodermal tissue into root components.
30-32
 
 Thus, the ultimate goal of the early work was to produce an infection-free root 
canal environment conducive to the formation of an apical barrier. 
 
APEXIFICATION 
 Apexification is defined as “a method of inducing a calcified barrier in a root with 
an open apex or the continued apical development of an incompletely formed root in 
teeth with necrotic pulp.”33 The technique relies basically on removal of the remaining 
necrotic pulp tissue and cleaning of the canal, followed by filling of the root canal with a 
temporary filling material that would promote the formation of a calcified barrier to 
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achieve an apical closure of the open apex.
34
 After positive radiographic and clinical 
assessment of the apical closure, the temporary material is replaced with a final gutta-
percha filling.  
 In general, since the introduction of the apexification concept, many technique 
variations with or without the application of medicaments have been advocated for use.
24
  
 
Calcium Hydroxide 
 Calcium hydroxide is one of the first used and most popular intracanal 
medicaments.
35
 In 1964 Kaiser first introduced the use of calcium hydroxide mixed with 
camphorated parachlorophenol (CMCP) to induce the formation of a calcified periapical 
barrier.
24
 Consequently, many studies have confirmed the successful outcome after using 
a combination of calcium hydroxide and CMCP.  Calcium hydroxide was also used along 
with Cresatin (Premier Dental Products), shown to be less cytotoxic and to induce a 
lower inflammatory potential compared with CMCP.
36,37
 In addition, calcium hydroxide 
was also mixed with saline, distilled, and sterile water in order to reduce the cytotoxic 
effect. Successful clinical outcomes have been reported using these combinations.
24
  
The mechanism by which calcium hydroxide induces the formation of an apical calcified 
barrier is still controversial. That is mainly because the calcium ions deposited in the 
apical barrier comes mainly from the bloodstream rather than the calcium hydroxide 
intracanal dressing.
38
  Mitchell and Shankwalker have confirmed the potential of calcium 
hydroxide to induce the formation of heterotopic bony tissue by being implanted into the 
connective tissue of rats.
39
  According to Holland et al., the periapical tissue reacts to 
calcium hydroxide in a way that is similar to the pulp tissue.
40
  Calcium hydroxide 
produces a multilayer necrosis in the periapical area that acts as a low-grade irritation 
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inducing a subjacent mineralization by the attraction of calcium ions into the newly 
formed collagenous matrix.
24,41
  It has been demonstrated that calcium hydroxide’s high 
pH as well as its antibacterial efficacy are the main properties contributing to its ability to 
induce the formation of the calcified barrier. Javelet et al. demonstrated that the alkaline 
pH of calcium hydroxide (pH 11.8) is more conducive to the formation of an apical 
barrier compared with a lower pH material, such as calcium chloride (pH 4.4). Several 
studies have confirmed the antibacterial efficacy of calcium hydroxide attributed to the 
release of hydroxyl ions.
42-44
 These ions are highly oxidative and can damage the 
bacterial cytoplasmic membrane and DNA.
24
 
 Calcium hydroxide can cause a localized increase in the calcium concentration, 
which can stimulate pyrophosphatase enzyme.
45
 This enzyme can facilitate the repair 
process by promoting collagen synthesis.  
 The calcified barrier may be composed of cementum, dentin, bone or 
osteodentin.
32
 Steiner and Van Hassel have shown that the apical calcified bridge can be 
histologically identified as a cementum-like material.
46
 Histological analysis of this ‘cap-
like’ bridge that extends over the root apex, revealed that it is composed of irregular dens 
fibrocollagenous core with calcified foci surrounded by an outer layer that is dens 
acellular cementum-like material. In regard to the clinical application, no agreement 
exists about the frequency of the calcium hydroxide dressing re-application. Authors who 
recommend a single application claim that calcium hydroxide plays a role only in 
initiating the healing reaction and that no benefit is to be gained from repeated 
applications.
24,47,48
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 Other authors suggest that monitoring the recurrence of clinical symptoms and 
making a radiographic assessment of the presence of the material in the canal are the best 
indications for evaluating the need to replace the dressing.
49,50
 However, other authors 
such as Abbot recommend the replacement of the dressing, because it allows for clinical 
monitoring of the bridge formation.
51
 Abbot also believes that radiographic assessment 
does not yield an accurate evaluation of whether the material has been washed out nor on 
the progress of the barrier formation.  
 The time required for complete formation of the apical barrier varies according to 
several factors. The stage of root development, the presence of pre-treatment periapical 
infection, and the rate of change of calcium hydroxide are all factors that have been 
considered by different authors.
24
 
 Clinically, either a calcium hydroxide paste or a powder that is mixed with saline 
can be used. The creamy paste should be packed against the apical soft tissue through the 
canal opening. The rest of the canal length should also be filled with calcium hydroxide 
to maximize the antibacterial efficacy and to prevent recurrent infection throughout the 
extended treatment period.
52
  Radiographic assessment of hard barrier formation should 
be conducted every three months. Evidence of material washout should also be checked 
to assess the need to replace the dressing. Unnecessary dressing changes should be 
avoided because the material’s initial toxicity could delay the healing process.53 
Complete formation of the calcified barrier could take between 6 to 18 months.  
 Despite the high success rate of the calcium hydroxide apexification technique, it 
still has some major disadvantages. The prolonged treatment period, which ranges from 
six to eight months, involves multiple follow-up sessions making patient compliance an 
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essential requirement.
52
  Failure of the patient to regularly appear at the follow-up 
appointments or loss of the temporary coronal filling between the appointments can 
seriously impact the outcome of this technique. Unpredictability of the apical barrier 
formation is another disadvantage of this approach.
54
 In addition, calcium hydroxide has 
been shown to weaken dentin by making it more susceptible to fracture, especially in 
immature teeth with thin dentinal walls.
55
  
 
Mineral Trioxide Aggregate 
 Due to the previously mentioned limitations of calcium hydroxide, several other 
materials have been considered for the treatment of necrotic immature teeth. Mineral 
trioxide aggregate (MTA) is a material that has been considered to replace traditional 
calcium hydroxide treatment. MTA was first introduced in 1993 and approved by the 
FDA in 1998.
24
  MTA is endodontic cement that consists of fine hydrophilic particles of 
tricalcium silicate, tricalcium oxide, and silicate oxide. It is a biocompatible material with 
low solubility. After setting, the material has a high pH (12.5), which imposes some 
antimicrobial effect.
56
  
 In 1999 Shabahang et al. tested the material’s ability to produce an apical barrier 
in immature teeth of a dog model. They concluded that MTA can successfully produce a 
consistent apical barrier.
57
 Several clinical studies have also reported successful results 
using MTA.
54
 
 Given the previously mentioned shortcomings of the traditional multiple-visit 
apexification technique, a one-visit apexification that involves the use of an apical plug 
was suggested. The idea behind this approach is to produce an apical stop that allows 
direct condensation of a permanent root filling material, such as gutta-percha, eliminating 
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the prolonged treatment time associated with the traditional technique. MTA has been 
successfully used as an apical plug material. In addition to expedited treatment, the use of 
MTA allows for the immediate placement of a bonded core inside the root canal, thus 
reinforcing the canal system and decreasing the risk of fracture. MTA is placed into the 
apical 3 mm to 4 mm of the canal, while the rest of the canal is filled with a permanent 
root filling material. A bonded resin restoration is then placed to reinforce the restored 
tooth.
52
  
 Apical closure with this technique is more predictable than with calcium 
hydroxide; however, similar to calcium hydroxide, this technique only treats the issue of 
the open apex and does not result in further root development.
54
   
 
TISSUE REGENERATION  
  The recent evolution in material science has greatly improved and expanded 
treatment options in terms of replacing damaged or lost dental structures. Nevertheless, 
these synthetic materials usually possess chemical, biological, and physical 
characteristics different from the host tissue.
58
  Mostly, these artificial substitutes only 
provide a structural rather than a physiologically functional replacement.
1
 Therefore, the 
long-term prognosis of traditional restorative approaches is often questionable.  
 The ultimate goal of any restorative treatment is to restore the tissue back to its 
original physiological and functional state.
59
  Although unsuccessful, the early attempts 
to regenerate pulp tissue go back to the 1960s and 1970s.
59
 Direct pulp capping, 
pulpotomy, and root canal revascularization are some of the earliest regenerative 
endodontic approaches in use since the 1970s.
60
 However, the lack of isolation and 
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characterization strategies of the stem cells has resulted in limited success, particularly in 
pulp tissue regeneration.  
 The emergence of modern tissue engineering technology has encouraged 
extensive research and advancements in the field of regenerative endodontics.
59
 Tissue 
engineering is a discipline that integrates the fundamentals of engineering, physics, 
chemistry and biology to develop materials and approaches that enable the regeneration 
of defective or lost tissues.
58,61
   
 The concept of endodontic tissue engineering relies on the interplay of three 
major components, namely, progenitor stem cells capable of differentiation to different 
cell types; growth factors that signal the proliferation and differentiation of the cells, and 
a three-dimensional scaffold that can support and provide structural integrity of the 
regenerated tissue.
62-64
  
 
REGENERATIVE ENDODONTIC PROCEDURES 
 According to the current Glossary of Endodontic Terms published by the 
American Association of Endodontists, regenerative endodontics is defined as 
“biologically-based procedures designed to physiologically replace damaged tooth 
structures, including dentin and root structures, as well as cells of the pulp-dentin 
complex.” 65 
 In the most recent clinical considerations for a regenerative procedure, the 
American Association of Endodontists stated three goals of regenerative endodontic 
treatment for necrotic immature teeth: primarily, resolution of symptoms and evidence of 
bone healing; secondarily, root development in the form of increased thickness and 
length, and thirdly, positive evidence of vital pulp tissue growth.
66,67
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 There have been several clinically successful published case reports. However, 
there are no adequately consistent results to support a specific regenerative protocol.
66
  
Based on the disinfection technique, two distinct pulp revascularization methods have 
been described in the literature.
68
 In the first technique, calcium hydroxide is used as 
intracanal medicament, while triple antibiotic paste is used in the other.  
 Regardless of the medicament used, the AAE has published a general treatment 
protocol consisting of three stages.
69,70
 After a thorough case evaluation and selection, the 
first stage involves chemical root canal disinfection using sodium hypochlorite. The AAE 
recommends using 1.5-percent NaOCl, however; higher concentrations up to 6 percent 
have been used in successful clinical case reports.
4,71
 After initial irrigation, a therapeutic 
root canal dressing consisting of either calcium hydroxide or antibiotic paste is placed 
inside the cleaned empty canal. The purpose of this step is to treat any persistent infection 
as well as complete disinfection of the root canal to provide a favorable environment for 
pulp tissue regeneration.
70
 In the second stage, which is typically performed in a separate 
appointment after 1 week to 4 weeks, the dressing is removed, and the canal is gently 
flushed with 17-percent EDTA. Then, the periapical tissue is lacerated using a sterile 
hand file to induce bleeding into the canal space. The aim of this step is to form a blood 
clot inside the root canal that will act as a natural scaffold for the recruited stem cells to 
regenerate the pulp tissue. The blood clot is also believed to help deliver SCAPs into the 
pulp canal space. Moreover, the disintegration of the platelets, which are a major 
component of the blood clot, leads to the release of growth factors essential for stem cell 
proliferation and differentiation. In the final stage, the bleeding is stopped and the canal is 
sealed with MTA; then a final restoration is carried out. A three-month interval follow-up 
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should be maintained to assess an indication of successful outcomes. Absence of clinical 
symptoms as well as radiographic evidence of bone healing and root development can 
take up to 2 years to be achieved.
66
  
 Published case reports document a successful outcome for a regenerative 
endodontic approach in the form of increased root length and width.
7
 A greater survival 
rate for teeth treated with regenerative endodontic procedures (100 percent) has been 
noted compared with teeth treated with a traditional MTA apexification approach (77 
percent).
9
  
 Despite these promising results, the biological outcome of the regenerative  
treatment approach is rather unpredictable.
70
  Bone healing and root development does 
not necessarily confirm the regeneration of the pulp dentin complex within the root 
canals. In fact, histological examination of the tissue formed inside the root canals of 
teeth treated with regenerative procedures reveals the apposition of a cementum-like 
tissue, which is responsible for the canal narrowing as well as for the length increasing.
72
 
Additionally, in-growth of a connective tissue similar to periodontal ligament along with 
a bone-like tissue was identified inside the root canals.
73
 These findings suggest the 
current endodontic regenerative protocols need careful consideration and review. The 
unpredictability of the results could be related to many factors. The disinfection 
technique is one of the most influential factors affecting the outcome of this approach.
1
 
There is a compelling level of evidence indicating that both irrigants and intracanal 
medicaments can greatly affect the survivability of the stem cells.
11,74,75
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ROOT CANAL DISINFECTION 
 One important factor in the success of regenerative endodontic treatments is the 
establishment of a high level of root canal disinfection. Regrettably, periapical abscesses 
and periodontitis are highly associated with necrotic immature teeth.
7
 In immature teeth, 
bacteria are more likely to penetrate deeply into the tissue rendering bacterial disinfection 
even more challenging.
76,77
  This step is usually accomplished using a combination of 
chemical irrigation and intra-canal medicaments. The current operative protocols vary 
considerably regarding the types and concentrations of the chemicals used. However, the 
majority of these protocols rely on initial root canal disinfection using sodium 
hypochlorite (NaOCl) or chlorhexidine (CHX) and EDTA followed by the application of 
intra-canal medicaments such as either calcium hydroxide (         ) or antibiotic paste 
(DAP or TAP).
66,78,79
 
 
Sodium hypochlorite 
 Sodium hypochlorite is one the most popular irrigants in endodontics. In addition 
to its antiseptic effect, NaOCl can also dissolve organic tissues including necrotic pulp 
remnants.
80
 It has been used in variable concentrations ranging between 0.5 percent and 
5.25 percent.
68
 At high concentrations, sodium hypochlorite is found to be toxic to stem 
cells and can hamper their attachment to the dentinal surface.
74,81
 Trevino et al. have 
shown that full-strength NaOCl is cytotoxic to stem cells and prevent their attachment to 
the dentinal surface of the root canals.
74
  Sodium hypochlorite cytotoxicity is proportional 
to its concentration.
68
  Martin et al. postulates that a concentration of 1.5-percent NaOCl 
is more favorable for the survival of stem cells as compared with a 3-percent NaOCl 
19 
 
    
 
concentration.
82
 Generally, normal saline should be used to flush sodium hypochlorite out 
of the root canal to reduce its residual toxic effect on the stem cells.  
 
Chlorhexidine 
 Chlorhexidine is known to have antimicrobial effects on gram positive bacteria 
and candida. At concentrations as low as 0.12 percent, CHX is known to be 
bacteriostatic, while it is bactericidal at higher concentrations. A concentration of 2 
percent is the most commonly recommended. The prolonged antimicrobial effect is the 
main advantage of CHX. In fact, it is adsorbed to the dentinal surface allowing for an 
extended release that continues up to twelve weeks. However, unlike NaOCl, CHX 
cannot dissolve organic tissue, which is considered a major disadvantage of CHX.
68
 
Moreover, CHX is found to be cytotoxic to stem cells.
74
  It is recommended to use 
normal saline between CHX and NaOCl in order to reduce the toxic effect of CHX 
precipitate.
83
  Based on these reasons, the use of CHX in regenerative endodontics should 
be avoided.
66
 
 
EDTA 
 Ethylenediamine tetra-acetic acid (EDTA) is a chelating agent that can strip 
inorganic components from the smear layer by binding divalent cations. Although it is 
not an antiseptic agent, EDTA can act synergistically with other irrigants (such as 
NaOCl) by increasing wettability of the dentin surface and removal of the smear layer. 
More importantly, EDTA is believed to stimulate the proliferation of stem cells by 
facilitating the release of growth factors as a result of its chelating effect. Additionally, 
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Trevino et al. found that using EDTA (17 percent) before irrigants increases the survival 
of stem cells.
74
 
 
Antibiotics 
 A wide variety of antibiotics and antibiotic mixtures have been used in endodontic 
regenerative procedures. The use of a double antibiotic paste consisting of metronidazole 
and ciprofloxacin was reported in the first successful regenerative case report.
94
 
Subsequently, a triple antibiotic paste consisting of metronidazole, ciprofloxacin, and 
minocycline became more popular after many successful case reports.
84-86
 However, 
minocycline was found to result in teeth discoloration.
20,87
 Different triple antibiotic 
combinations have been tested; however, minocycline containing combinations are found 
to achieve the best results, especially in providing increased root thickness.
10
 In fact, 
triple antibiotic paste containing minocycline has the ability to diffuse deeply in root 
dentin resulting in better disinfection of the deeper layers.
88,89
  Despite its proven 
antibacterial efficacy, TAP is found to be cytotoxic for the stem cells, which is a major 
drawback for its use in regenerative endodontics.
11,72,90
 Ruparel et al. have shown that the 
widely used creamy paste (1000 mg/mL) of a triple antibiotic mixture is toxic to SCAP.
11
 
Althumairy et al. postulated that the toxicity of TAP depends on the concentration. 
According to Ruparel et al., concentrations between 0.01 mg/mL to 0.1 mg/mL promote 
SCAP survival.
11
 However, such low concentrations result in a watery mixture that  
cannot be retained inside the root canals, thus posing a clinical difficulty for using such as 
low concentration.
70
 Therefore, it would be beneficial to use a biocompatible scaffold to 
deliver the antibiotic at  lower concentrations.
70
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 Several studies have proven the antibacterial efficacy of drug delivering scaffolds 
through controlled release of the incorporated antibiotic.
91, 92
 Recent studies using a novel 
electrospun polymer-based bioactive scaffold suggest that the scaffold can release small 
yet effective antibiotic concentrations, which should have much lower detrimental effects 
on the survival of SCAP.
22, 93
 In fact, in our current study an antibiotic concentration of 
35 wt% was used to synthesize the scaffold yielding a total amount of less than 10 mg of 
TAP per scaffold, which represents only 1 percent of the total amount of antibiotic in the 
currently used triple antibiotic paste (1000 mg/mL).  
 
Scaffolds 
 In order for stem cells to migrate and proliferate within the empty canal space, 
there must be a structural unit that can support this new growth.
62
 A scaffold is a three-
dimensional extra-cellular matrix mimicking temporary microstructure that can support 
and regulate cell proliferation, differentiation, and function.
94,95
  Ideally, a scaffold should 
possess certain biomechanical properties that favor and support new cellular growth. 
Essential characteristics for a successful scaffold are biocompatibility; capability of 
seeding the stem cells and the delivery of growth factors; and bioactivity to facilitate cell 
adhesion and angiogenesis.
70
  Mechanically, a scaffold should be rigid enough to sustain 
in-vivo stress.
58
 Micro and nano-porosity is critical for cell seeding and transfusion of 
nutrients.
96,97
  High porosity favors cellularity; however, it reduces mechanical 
strength.
98,99
 Controllable biodegradability is one of the most critical properties of the 
scaffold. The scaffold material should degrade at a rate compatible with the growth of 
new host tissue.
100
 Moreover, the biodegradation products should be non-toxic and easily 
eliminated.
101
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 Traditionally in regenerative endodontics, the most used scaffold is a blood clot,  
formed by laceration of the apical tissue of a cleaned pulp canal in an immature tooth 
with necrotic pulp. This natural scaffold provides an environment conducive to the 
growth of recruited stem cells (mostly SCAPs) within the emptied root canal.
26
 However, 
the unpredictability of the results as well as uncertainty regarding the type of regenerated 
tissue has nourished the search for an alternative scaffold.
72,102
  
 Generally, there are three basic types of scaffolds:  
 Natural – collagen and glycosaminoglycan, and platelet rich plasma (PRP).
 Synthetic – poly-L-lactic acid (PLLA), poly-glycolic acid (PGA), and their 
copolymers, poly-lactic-co-glycolic acid (PLGA). 
 Mineral scaffold – hydroxyapatite and calcium phosphate. 
 Several studies report successful results using natural scaffolds such as collagen 
and PRP scaffolds in regenerative endodontics; nevertheless, positive histological 
indications regarding the nature of the newly formed tissue have not been established.
70,72
  
 Synthetic polymer scaffolds such as PLLA, PGA, and PLGA are commonly used 
in tissue engineering. Using different manufacturing techniques, these polymers can be 
shaped into micro or nanoporous three-dimensional structures. Such scaffolds have many 
favorable properties that enhance their potential role in the advancement of tissue 
regeneration. Great surface area, enhanced cellular adherence, the ability to deliver 
controlled levels of antimicrobial substances and growth factors, and controllable 
biodegradability are the most important properties of these synthetic scaffolds.
1
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Electrospun scaffolds 
 The technology of electrospinning has been recently used to fabricate nanofibrous 
medicated scaffolds for tissue regeneration in dentistry with promising initial results.
103-
105
  The nanotechnology allows for controlling fiber diameter and morphology to produce 
customized 3D scaffolds that fulfill the mechanical and structural demand for their use in 
regenerative endodontics. In addition to providing an extracellular matrix mimicking the 
skeleton for cell integration and proliferation, these scaffolds can be used to deliver 
different antibiotics and growth factors essential for infection eradication and stem cell 
differentiation, respectively. The most important advantage of such scaffolds is their 
ability to release low and controllable amounts of antibiotics with sustainable 
antibacterial efficacy without jeopardizing the survivability of the stem cells.
21,22,104,106
  
 The FDA-approved polydioxanone (PDS) synthetic polymer was used to 
synthesize nanofibrous scaffolds for regenerative endodontics in several recent 
studies.
12,21,22,103,106
  PDS elicits a minimal inflammatory response compared with other 
synthetic polymers such as Dexon and Vicryl.
107
 In addition, it has high mechanical 
strength and a slow degradation rate, which are suitable properties to sustain the 
functional demand for use as an endodontic scaffold.
107
 
 The incorporation of different drugs and growth factors into electrospun scaffolds 
is the focus of many ongoing research studies. In this study, we incorporated a triple 
antibiotic mixture (35 wt% ciprofloxacin, 35 wt% metronidazole, and 35 wt% 
minocycline) into the PDS nanofibrous scaffold to investigate the antibacterial efficacy of 
a novel 3D tubular-shaped drug delivery system.  
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ANTIMICROBIAL ASSAY 
 The complete eradication of infection in the root canal and the surrounding 
dentinal tubules is fundamental for the success of regenerative endodontics. Hence, the 
efficacy of a new intracanal medicament must be verified using an experimental tool that 
has the ability to assess these results with a high level of accuracy.
108
  In chronic 
infections, bacteria penetrate deep into dentinal tubules and form a bacterial biofilm, 
which if not completely eradicated, can cause recurrent infection and thus failure of the 
endodontic therapy. Unfortunately, scanning electron microscopy can only be used to 
verify and measure the penetration of bacteria within the dentinal tubules and cannot give 
quantitative information about  bacterial viability.
108
  
 
Confocal Laser Scanning Microscopy (CLSM) 
 CLSM is an imaging technology that enables the capturing in-depth images with 
high resolution.
109
 The technique relies on an optical sectioning feature that allows for 
depth selectivity. Three-dimensional reconstruction of the thin (0.5 μm to 1.5 μm) 
consecutive sections using computer software results in the production of a topological 
three-dimensional image of the specimen.  
 The use of CLSM in biofilm research started in the 1990s.
110
 The increased focus 
on this technique in biofilm studies is attributable to the ability of CLSM to obtain a 
series of high-quality images of hydrated living sections with simple non-invasive 
preparation.
110,111
 Currently, there are over 150 published papers that have used CLSM 
for oral biofilm analysis.
111
 Similar to traditional light microscopy, CLSM specimen 
visualization is accomplished through the stimulation of fluorescent light emission using 
a low-power laser beam.
111,112
 However, CLSM relies on the technology of spatial 
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filtering to eliminate out-of-focus light to produce images of well-defined sections.
112
  
Using CLSM is especially beneficial for the purpose of our current study. CLSM uses  
certain dyes to yield information about the viability of the bacterial biofilm that may have 
grown deeply inside the dentinal tubules. Thus, we are able to report more accurate 
results regarding the antibacterial efficacy of our antibiotic-containing scaffold, not only 
on the surface, but also in the deeper layers of the dentin specimen.   
 Fluorescence is the most beneficial imaging mode in biological CLSM. 
Fluorescent probe technology offers a high level of sensitivity with the ability to monitor 
specific dynamic processes and cellular integrity.
112
  The LIVE/DEAD BacLight 
bacterial viability kit is used to gather quantitative data regarding bacterial viability. The 
kit is composed of two dyes: SYTO 9 and propidium iodide. The former has the ability to 
penetrate most bacterial membranes, while the latter penetrates only damaged cell 
membranes.
113
 Therefore, when these dyes are applied together, viable cells with intact 
membranes will yield green fluorescence, while cells with damaged membranes will 
yield red fluorescence.
114
  After in situ reconstruction of the images, bacterial 
quantification is performed using a digital image analysis tool. 
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ELECTROSPUN 3D SCAFFOLDS SYNTHESIS 
Polydioxanone (PDS II/ PDS, PDSII, Ethicon) suture wires were cut into small 
pieces and immersed in dichloromethane solution (Sigma, Aldrich, St. Louis, MO) for the 
undying process. After 48 h, 1,1,1,3,3,3-hexafluoro-2-propanol (HFP, Sigma Aldrich) 
solution was added to the fibers at a 1:10 weight ratio in order to prepare the polymer 
solutions. Afterwards, three antibiotics powder namely metronidazole, ciprofloxacin, and 
minocycline were added to the polymer solution to prepare the triple antibiotic paste 
(TAP)-mimic scaffolds (at 35 wt.% of each drug). Thus, a total of 210 mg (relative to the 
PDS 600 mg) of each drug was incorporated into the solution. Pure antibiotic-free PDS 
solution, was prepared to synthesize control scaffolds. After 24 h of stirring, each 
solution was loaded individually into plastic syringes (Becton, Dickinson and Co., 
Franklin Lakes, NJ) fitted with a metallic 27-gauge blunt tip  needle. Then, it was 
electrospun using an electrospinning system (Figure 1)  consisting of a high-voltage 
source (ES50P-10W/DAM, Gamma High-Voltage Research Inc., FL), a syringe pump 
(Legato 200, KD Scientific Apparatus, Holliston, MA), and a Teflon-coated collecting 
steel mandrel (1.5 mm ± 0.02) connected to a high-speed mechanical stirrer (BDC6015, 
Caframo, Wiarton, ON) (Figure 2).  The processing parameters were set up as follows: 
flow rate 2 mL/h, the distance between the needle tip and the collecting mandrel was 18-
cm, and electrical voltage between 15 and 19 kV. 
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The collected tubular-shaped fibrous scaffolds were then cut into multiple 
specimens (1 mm height ± 0.1) (Figure 3) and dried under vacuum for at least 48 h to 
ensure complete removal of any remaining solvent. 
 
DENTIN SAMPLE PREPARATION  
Twenty-four caries-free human canines, collected under an approved (protocol 
#1407656657) local Institutional Review Board protocol (Indiana University), were 
cleaned and stored in 0.1-percent thymol.  After removal of the crown using a low-speed 
water-cooled rotary saw with a thin wafering blade (Isomet, Buehler, Lake Bluff, IL), the 
roots were horizontally sectioned at 3 mm apical to the cement-enamel junction, to obtain 
1.5-mm high ( ± 0.1)  dentin slices (Figure 4). The specimens were wet-finished with SiC 
papers (800 grit) until they reached a uniform 1-mm thickness. The root canals were 
enlarged using a round bur (2.5 mm in diameter) at low speed (300 rpm) under water-
cooling. To remove the smear layer, all specimens were immersed first in 2.5-percent 
NaOCl for 3 minutes in an ultrasonic bath (L&R 2014 Ultrasonic Cleaning System, NJ) 
(Figure 5) and washed using distilled water followed by immersion in 17-percent 
ethylenediamine tetraacetic acid (EDTA-Inter-Med. Inc., WI) and sonication for another 
3 minutes.
115
 After final rinsing with distilled water, all specimens were autoclaved 
(121°C for 20 min).  
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A. NAESLUNDII – BIOFILM FORMATION 
IN THE DENTINAL TUBULES 
Five mL of brain heart infusion broth (BHI) was inoculated with a single colony 
of A. naeslundii (ATCC 43146) from a blood agar plate containing a pure culture of the 
bacterium and incubated at 37ºC in 5-percent CO2 for 16 h to 18 h.  All dentin specimens 
were randomly placed in sterile microcentrifuge tubes containing 500 µL of A. naeslundii 
suspension pipetted on top of the dentin specimens (Figure 6). The tubes were 
centrifuged twice at 1400 g, 2000 g, 3600 g, and 5600 g in a sequence each for 5 minutes 
(Figure 7).
116
 The bacterial suspension was refreshed between every centrifugation cycle, 
and the solution that penetrated through the dentin slice was discarded. The inoculated 
dentin specimens were distributed into 24 well plates containing 1 mL of BHI + 1-percent 
sucrose (BHIS). The plates were incubated in aerobic conditions at 37°C and 5-percent 
CO2 for 7 days for biofilm formation. The BHI broth was replaced every other day to 
remove dead cells and ensure bacterial viability. After 7 days of biofilm formation, the 
dentin specimens were gently rinsed with sterile phosphate-buffered saline (PBS) to 
remove the culture medium and non-adherent bacteria. Afterwards, the infected dentin 
specimens (n = 24) were randomly allocated into two experimental groups: tubular-shape 
TAP-mimic scaffolds, and TAP solution (50 mg/mL of each of the drugs), and two 
negative control groups (7-day biofilm, untreated and pure PDS). Tubular-shaped 
scaffolds were sterilized by UV-irradiation (30 min/side) and fitted inside the infected 
root canal spaces of TAP-mimic and pure PDS groups (Figure 8 to Figure 10).   Triple 
antibiotic paste was prepared into a creamy consistency by mixing 50 mg each of 
metronidazole, minocycline, and ciprofloxacin with 1 mL of distilled water. The prepared 
TAP was applied into the root canal spaces of the third group (Figure 11). The 
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medicaments remained for 7 days. To maintain a humid environment and prevent the 
TAP and TAP-mimic scaffolds from drying out, a damp cotton ball saturated with 50 µL 
of distilled water was placed on top of each specimen. After 7 days, 4 of the 6 specimens 
of each group were washed in PBS twice and prepared for CLSM live/dead staining.  The 
other 2 specimens of each group were prepared for SEM analysis.  
 
Scanning Electron Microscopy (SEM) 
  Briefly, after biofilm formation/intracanal medicament exposure, the dentin 
samples (2 samples × 4 groups) were carefully removed from the wells using a sterile 
forceps and gently washed with PBS to remove non-adherent bacteria. The specimens 
were split in the middle using a sterile enamel hatchet positioned perpendicular to the flat 
specimen’s surface and pressure applied until the specimens split into two halves. Next, 
the specimens were fixed in 2.5-percent glutaraldehyde for 24 hours and dehydrated in 
increasing concentrations of alcohol solutions (10%, 25%, 50%, 75%, 90% and 100%). 
The samples were mounted on aluminum stubs, sputter coated with gold and imaged by 
SEM (Figure 12). The dentin wall surfaces of the root canals were analyzed to verify the 
presence of biofilm (Figure 13).  
 
Confocal Laser Scanning Microscopy (CLSM) 
For CLSM analysis, 4 specimens from each of the 4 groups were stained with the 
fluorescent LIVE/DEAD BacLight Bacterial viability Kit L-7012 (Molecular Probes, 
Eugene, OR, USA) containing SYTO 9 and propidium iodide (PI). The stained 
specimens were assessed with a CLSM (Leica SP2 CL5Mt, Leia Microsystems Inc. 
Heidelberg. Germany) using an X40 lens. The excitation emission maxima for the dyes 
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are approximately 480/500 nm for SYTO 9 and 490/635 nm for PI (Figures 14 and 15). 
Two random areas, measuring 0.9 × 0.9 mm
2
 provided by a mosaic technique, of each 
dentin specimen were randomly selected starting from the root canal space toward the 
cementum (Figure 15) to be analyzed on CLSM by 3D reconstruction. Each mosaic 
consisted of 9 (0.3 × 0.3 mm
 2
) sub-areas (Figure 16). LIVE/DEAD images were 
analyzed and quantified using dedicated software (Imaris 7.2 software, Bitplane Inc., St. 
Paul, MN).  
 
Statistical Analysis 
 The percentages of green live/red dead bacteria were compared for differences of 
dead bacterial cells using a mixed-model ANOVA, with a fixed effect for group and a 
random effect for sample, to account for measurements at multiple areas on each 
specimen. All tests were performed using a 5-percent significance level.  
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CLSM scans and 3D reconstructions of the images of the 7-day biofilm control 
group showed a dense penetration of A. naeslundii deep in the dentinal tubules (Figure 
17) with a dominant green color indicating the heavy presence of viable A. naeslundii 
inside the dentinal tubules. Bacterial viability for this group was between 99.88 and 
99.99%.  The PDS negative control group (Figure 18) also showed a high percentage of 
bacterial viability ranging between 98.01 percent and 99.34 percent. The proportion of 
dead bacterial cells in the 3D-TAP (Figure 19) ranged from 99.1 percent to 99.94 percent 
which was significantly different compared to the control PDS group (p < 0.05). The 
TAP solution group showed a 100-percent reduction in bacterial viability (Figure 20). 
However, there was no statistically significant difference between the results of the TAP 
solution and the 3D-TAP groups. Table I summarizes the results of the bacterial viability 
of the four groups.  
Similarly to CLSM, SEM verified the penetration of A. naeslundii into the 
dentinal tubules from the root canal side after centrifugation and incubation of these 
specimens. SEM images showed apparent infection of the dentinal tubules in the 7-day 
biofilm control and the PDS groups (Figure 21 and Figure 22). Both of the TAP solution 
3D-TAP groups showed bacterial-free dentinal tubules (Figure 23 and Figure 24). 
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       FIGURE 1.  Image of electrospinning set-up used in the current study located in 
Dr.   Bottino’s laboratory.  
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FIGURE 2.      Image showing the fibrous’ collection and 3D scaffold 
fabrication on the rotating mandrel of the electrospinning 
apparatus. 
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           FIGURE 3.  Tubular electrospun scaffold after being formed on the 
Teflon-coated rotating mandrel during the electrospinning  
process. This shows how the scaffold was cut to 1 mm 
height 3D-scaffolds. 
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FIGURE 4.   Schematic drawing showing the dimensions of the dentin specimen. 
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FIGURE 5. Image showing NaOCl and EDTA solutions and the  
ultrasonic bath used to clean the prepared specimens.  
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FIGURE 6.  Dentin specimens placed inside microcentrifuge tubes with 
500 µL of BHIS broth. 
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FIGURE 7. Image showing the centrifuge machine loaded 
with microcentrifuge tubes containing the 
dentin specimens. 
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              FIGURE 8. Images showing fitting the 3D scaffold inside the canal 
space of the dentin specimen. 
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                       FIGURE 9.  Image showing dentin specimens with 3D TAP 
scaffolds (experimental group) placed inside 24 
well plates. 
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FIGURE 10. Image showing dentin specimens with 3D 
scaffolds (control group) placed inside 24 
well plates. 
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                     FIGURE 11. Image showing: A. The mixed TAP solution; 
and B. Placement inside the root canal space of 
a dentin slice. 
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FIGURE 12. Sputter coating of the specimens 
prior to SEM imaging. 
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                   FIGURE 13. SEM image (original magnification X60) of the root 
canal surface which will be analyzed to verify the 
presence of the bacterial biofilm. 
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FIGURE 14.      Confocal laser scanning microscope. 
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FIGURE 15. Image showing the stained dentin specimens viewed 
under the CLSM lens. 
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FIGURE 16.  Schematic drawing showing the areas scanned by CLSM. 
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       FIGURE 17.  CLSM macrophotographs of 7-day A. 
naeslundii biofilm (negative control) 
growth inside dentinal tubules. 
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   FIGURE 18.  CLSM macrophotographs of infected dentin 
treated with pure PDS. 
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FIGURE 19. CLSM macrophotographs of infected 
dentin treated with 3D TAP-mimic 
scaffold. 
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FIGURE 20.     CLSM macrophotographs of infected 
dentin treated with TAP. 
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     FIGURE 21. SEM images (original magnification, X2500 and 
X10000) of A. naeslundii biofilm on the dentin 
surface (negative control).  
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  FIGURE 22.   SEM images (original magnification, X2500 and      
X10000) of infected dentin specimen treated with pure 
PDS. 
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FIGURE 23.     SEM images (original magnification, X2500 and 
X10000) of infected dentin specimen treated with 3D 
TAP-mimic scaffold. 
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FIGURE 24.     SEM images (original magnification, X2500 and 
X10000) of infected dentin specimen treated with TAP. 
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FIGURE 25.      Graph representing comparison of live bacteria percentage for each of 
the four groups. 
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TABLE I 
    Percentage of live and dead bacterial cells based on CLSM analysis 
 
 Groups 
N 
Areas 
N 
Samples 
Min 
 
Max 
% 
Median 
 
D
ea
d
 
Control 16 4 0.01 0.12 0.03 
PDS 16 4 0.66 1.99 1.2 
3D-TAPs 16 4 99.1 99.94 99.8 
TAP 16 4 100 100 100 
L
iv
e 
Control 16 4 99.88 99.99 99.97 
PDS 16 4 98.01 99.34 98.77 
3D-TAPs 16 4 0.06 0.99 0.21 
TAP 16 4 0 0 0 
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Regenerative endodontic procedures for treating immature teeth with necrotic 
pulp have been increasingly utilized and investigated over the past decade.
117
 Compiling 
successful clinical reports for cases treated with REPs have provided an evidence based 
strategy to replace the traditional apexification approach. In fact, recent studies suggest 
that the anticipated positive outcomes of REPs rationalize the use of this approach over 
the traditional apexification even if the achievement of the ultimate goal of pulp re-
vitalization is questionable.
66
  
Despite some variations, most of the current regenerative protocols emphasize 
infection control as an essential step in the regenerative endodontic procedures.
7,11,12
 
Due to the fact that mechanical debridement (instrumentation) is not recommended in 
cases of necrotic immature teeth, disinfection of the root canals is heavily dependent on 
chemical treatment. Thus, any proposed disinfectant should be able to eradicate bacteria 
and bacterial biofilm deep in the dentinal tubules to eliminate the chance of recurring 
infection. In vitro infected dentin models have been used to test the efficacy of different 
disinfectants used in root canal disinfection.
118-120
 However, traditional broth cultured 
dentin specimens often fail to produce heavy infection inside the dentinal tubules.
121
 In 
addition, quantitative comparison of live/dead bacteria between the specimens is nearly 
impossible due to the great variation between the specimens.
121
  In this study, a 
centrifugation protocol was used to force the bacteria inside the dentinal tubules. In fact, 
this model was based on previous studies which have proven the efficacy of 
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centrifugation in producing multiple infected specimens with comparable amounts of 
bacteria 
116,121
 Happasalo et al. have performed extensive pilot testing on the time and 
force sequence used in the current centrifugation protocol.
116
 It was found that shorter 
centrifugation cycles did not allow the bacteria to move deeper inside the tubules. A 
gradual increase in g force prevented bacterial accumulation on the dentin surface and 
allowed for deeper penetration inside the dentinal tubules. SEM and CLSM images of our 
seven-day biofilm control group clearly show deep penetration of A. naeslundii inside the 
dentinal tubules, and this result validates the efficacy of this protocol in producing deep 
bacterial infection. 
The antibacterial efficacy of TAP mimic scaffold has been investigated in 
previous studies. Albuquerque et al. have studied in vitro the effects of a (TAP)- mimic 
polymer nanofibrous scaffold against P. gingivalis-infected dentin biofilm.
117
 They 
concluded the PDS-based TAP-mimic scaffold has a significant antimicrobial efficacy 
against an established P. gingivalis-infected dentin biofilm. In a different study, the novel 
TAP-mimic scaffolds promoted a significant reduction in A. naeslundii biofilm formed 
on human dentin.
103
  Similarly, the current study further proved the efficacy of the TAP-
mimic scaffolds against A. naeslundii biofilm. However, the main advancement from the 
previous studies is the use of a more clinically relevant test model. Previous in-vitro 
studies have used a square (4 4 1 mm³) dentin model to provide preliminary data 
regarding the antibacterial efficacy of the TAP-mimic scaffold.  The positive initial 
results have promoted the development of a model that is more simulative to the 
proposed clinical application of this therapeutic scaffold. The nature of the root canals, as 
well as, the arrangement and distribution of the dentinal tubules poses a unique 
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anatomical challenge for the placement of the scaffolds and the action of the incorporated 
medicaments.  
To our knowledge, this is the first study that develops a three-dimensional model 
to study the antimicrobial efficacy of the TAP-mimic electrospun scaffold. The tubular 
scaffold was fitted inside the root canal space of a dentin slice obtained from the mid-
section of a human canine root. This model allows testing the efficacy of the 3D tubular 
scaffold against the bacterial biofilm, not only on the surface in contact with the scaffold, 
but also deeper inside the dentinal tubules. In fact, based on the CLSM analysis, the 3D 
TAP mimic scaffold has shown antibacterial effect against A. naeslundii biofilm that is 
comparable to the efficacy of the TAP (Figure 24), which is considered a gold standard 
for REPs. The scaffold should be in intimate contact with the dentinal wall of the root 
canal in order to allow efficient release of the antibiotics to act against the bacterial 
biofilm formed deep inside the dentinal tubules. 
Collectively, the promising results of this study, in addition to similar ongoing 
studies in this laboratory on different bacterial species, should promote the advancement 
of this research to a preclinical animal research model. Such research will provide 
important consideration regarding the proposed clinical application of the 3D TAP-mimic 
scaffold. Insertion and removal techniques as well as the interaction of the TAP-mimic 
scaffold with the root canal environment should be addressed in future research. 
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SUMMARY AND CONCLUSION 
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Based on the present results, our null hypothesis was rejected because 3D 
electrospun TAP-mimic scaffold significantly reduced the percentage of viable A. 
naeslundii bacteria. The TAP mimic-scaffold showed an antimicrobial activity  
comparable to the TAP solution. 
In fact, the TAP-mimic scaffold used in this study showed antimicrobial activity 
comparable to TAP, despite the lower concentration of antibiotics present in the scaffold 
(i.e., ~3.3 mg) as opposed to 1 g/mL in the TAP.  
This scaffold has the potential to replace the currently used TAP. Moreover, it has 
the potential to improve the outcome of the regenerative endodontic approach by serving 
as an extra-cellular matrix-mimic scaffold for new tissue growth in addition to the 
controllable drug release.  
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THE ANTIMICROBIAL EFFICACY OF INNOVATIVE 3D TRIPLE 
ANTIBIOTIC PASTE-MIMIC TUBULAR SCAFFOLD  
AGAINST ACTINOMYCES NAESLUNDII 
 
 
 
by 
Asma Azab 
 
Indiana University School of Dentistry 
Indianapolis, Indiana  
 
Background: Root canal disinfection is an essential requirement for the success of 
regenerative endodontics. Currently, the so-called triple antibiotic paste (TAP) is 
considered the standard of care. Notwithstanding the good antimicrobial capacity, the 
high concentration of TAP has shown significant toxicity to human cells, especially 
dental pulp stem cells. A novel drug release system, i.e., a triple antibiotic paste-mimic 
electrospun scaffold containing low concentrations of the antibiotics present in the TAP, 
has emerged as an effective and reliable alternative to fight root canal infections without  
potential toxic effects on dental stem cells, which are an integral part of the regenerative 
treatment.  
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Objectives: The aim of this study was to determine the antimicrobial efficacy of 
an innovative three-dimensional (3D) triple antibiotic paste-mimic tubular scaffold 
against Actinomyces naeslundii biofilm formed inside human root canal dentinal tubules. 
Materials and methods: Pure polydioxanone (PDS) polymer solution and PDS 
loaded with metronidazole, ciprofloxacin and minocycline (35 wt.% of each antibiotic, 
3D-TAP-mimic scaffold) were spun into 3D fibrous scaffolds. A. naeslundii (ATCC 
43146) was centrifuged to induce biofilm formation inside human root canal dentinal 
tubules using a dentin slice model (1 mm thickness and 2.5 mm canal diameter). The 
infected dentin slices were exposed to the 3D-TAP-mimic scaffold, TAP solution (50 
mg/mL of each antibiotic), and antibiotic-free PDS. Biofilm elimination was 
quantitatively and qualitatively analyzed by confocal laser scanning microscopy (CLSM) 
and scanning electron microscopy (SEM), respectively.  
Results: A dense penetration of A. naeslundii biofilm was observed by CLSM 
throughout the dentinal tubules. 3D-TAP-mimic scaffold significantly reduced the 
percentage of viable bacteria compared with PDS (p <.05).  TAP solution completely 
eliminated viable bacteria without differing from 3D-TAP-mimic scaffolds. SEM images 
showed results similar to CLSM.  
Conclusion: Collectively, the proposed tubular 3D-TAP-mimic scaffold holds 
significant clinical potential for root canal disinfection strategy prior to regenerative 
endodontics. 
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